JAMA Network
About The Study: The decreases in cancer screening during the early phases of the COVID-19 pandemic did not resolve after the initial pandemic surges in this study of Medicare enrollees from March 2020 through July 2022. Successful interventions to improve screening rates should address pandemic-specific reasons for low screening participation.
Authors: James S. Goodwin, M.D., of the University of Texas Medical Branch in Galveston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.55589)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
